3i, LP 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 9:02 pm Purchase | 2025-02-05 | 13G | BriaCell Therapeutics Corp. BCTX | 3i, LP | 369,000 9.900% | 369,000 (New Position) | Filing |